NR 565 Midterm Study Guide
1.drug schedules - schedule I: Drug Schedules
no currently accepted medical use and for
research use only high potential for abuse
examples:
heroin
LSD
MDMA (3,4-Methyl enedioxy methamphetamine: AKA ecstasy)
2.drug schedules - schedule 2: combination drugs w/ < 15mg hydrocodone per dosage
unit High potential for abuse and severe physical/psychological dependence
examples:
Vicodin, cocaine, methamphetamine, methadone, Dilaudid, oxycodone, Meperidine,
Fentanyl, Adderall, Ritalin
3.drug schedules - schedule 3: drugs w/ <90 mg of codeine per dosage unit abuse
would lead to mod-low physical dependence and high psychological dependence
examples: ketamine, tylenol w/ codeine, anabolic steroids, testosterone
4.drug schedules - schedule 4: low potential for abuse; low level of dependence
examples:
xanax, Soma, Darvon, Valium, Ambien, Tramadol
5.What problems arise when prescriptive authority is limited?: Limited prescriptive
authority creates numerous barriers to quality, affordable, and accessible patient
care 6. drug schedules - schedule 5: very low potential for abuse/dependence
Examples:
Robitussin, Lomotil, Motofen, Lyrica, Parepectolin
1/7
, 7. Full Prescriptive Authority: Full prescriptive authority affords the legal right to
prescribe independently and without limitation
8. who mandates prescriptive authority?: Physicians can limit the types of drugs that
the APRN can prescribe
health professional boards
State laws place additional restrictions with regard to controlled drugs (full, restricted,
etc.)
9. responsibilities of prescribing: *safe and competent prescribing must have a
documented patient-provider relationship no personal prescribing! documented
thorough H+P
discussion of side effects, risks/benefits, alternative
options documented plan for monitoring/titration etc.
if applicable
consider cost, availability, CPGs, compatibility, indication
10. patient reasons for medication non-adherence: cost, availability, adverse effects,
complicated regimen, lack of education, disbelief in med importance, supply/missed
pick-up
11. what type of evidence prescribers should use to make treatment
recommendations: Current Clinical Practice Guidelines
12. Prescriptive considerations for older adults: decreased renal function--> serum
drug accumulation polypharmacy
increased illness
other comorbidities (CHF, cirrhosis, CKD,
DM etc.) lower therapeutic index
2/7
1.drug schedules - schedule I: Drug Schedules
no currently accepted medical use and for
research use only high potential for abuse
examples:
heroin
LSD
MDMA (3,4-Methyl enedioxy methamphetamine: AKA ecstasy)
2.drug schedules - schedule 2: combination drugs w/ < 15mg hydrocodone per dosage
unit High potential for abuse and severe physical/psychological dependence
examples:
Vicodin, cocaine, methamphetamine, methadone, Dilaudid, oxycodone, Meperidine,
Fentanyl, Adderall, Ritalin
3.drug schedules - schedule 3: drugs w/ <90 mg of codeine per dosage unit abuse
would lead to mod-low physical dependence and high psychological dependence
examples: ketamine, tylenol w/ codeine, anabolic steroids, testosterone
4.drug schedules - schedule 4: low potential for abuse; low level of dependence
examples:
xanax, Soma, Darvon, Valium, Ambien, Tramadol
5.What problems arise when prescriptive authority is limited?: Limited prescriptive
authority creates numerous barriers to quality, affordable, and accessible patient
care 6. drug schedules - schedule 5: very low potential for abuse/dependence
Examples:
Robitussin, Lomotil, Motofen, Lyrica, Parepectolin
1/7
, 7. Full Prescriptive Authority: Full prescriptive authority affords the legal right to
prescribe independently and without limitation
8. who mandates prescriptive authority?: Physicians can limit the types of drugs that
the APRN can prescribe
health professional boards
State laws place additional restrictions with regard to controlled drugs (full, restricted,
etc.)
9. responsibilities of prescribing: *safe and competent prescribing must have a
documented patient-provider relationship no personal prescribing! documented
thorough H+P
discussion of side effects, risks/benefits, alternative
options documented plan for monitoring/titration etc.
if applicable
consider cost, availability, CPGs, compatibility, indication
10. patient reasons for medication non-adherence: cost, availability, adverse effects,
complicated regimen, lack of education, disbelief in med importance, supply/missed
pick-up
11. what type of evidence prescribers should use to make treatment
recommendations: Current Clinical Practice Guidelines
12. Prescriptive considerations for older adults: decreased renal function--> serum
drug accumulation polypharmacy
increased illness
other comorbidities (CHF, cirrhosis, CKD,
DM etc.) lower therapeutic index
2/7
